Access Barriers Remain After Abortion Pill Decision
The Court rejected a challenge to FDA approval of mifepristone, but other obstacles could still impede access.
How Patents Contribute to High Drug Prices
Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.
Patents Do Not Bar Public Pharma Policies
Merck misconstrues patent law in its recent Takings Clause challenge to Medicare’s price negotiation program.
Patent Law Could Also Limit Mifepristone Access
Existing patents deter the marketing of more affordable generic drugs that could be used off-label for abortions.
FDA’s Role in Access to Reproductive Health Care
Recent abortion pill litigation underscores the significance of calls to make birth control pills available over the counter.